ALB and cancer: The neutrophil-albumin ratio (NAR), platelet-lymphocyte ratio (PLR), and C-reactive protein (CRP)-albumin ratio (CAR) are other promising biomarkers for use in patients with cancer, sepsis, and heart failure [5-7].